Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Arkansas.
Press releases published on April 29, 2025
Brick Technology Completes Second Acquisition in Six Months with LaadMaar Deal
GlobeNewswire
·
April 29, 2025
Pluggo acquisition strengthens Brick’s leadership in the European festival charging market following the earlier Volt deal. Brick Technology Logo STOCKHOLM, April 29, 2025 (GLOBE NEWSWIRE) -- Brick Technology AB (“Brick”), a Swedish consumer tech company …
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
GlobeNewswire
·
April 29, 2025
DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first …
Mainz Biomed Enters into Technology Partnership with EDX Medical Group
GlobeNewswire
·
April 29, 2025
BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, has entered into a technology …
Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders
GlobeNewswire
·
April 29, 2025
Ingelheim, Germany, Oxford and Belfast, UK, April 29, 2025 – Boehringer Ingelheim, the University of Oxford, and Cumulus Neuroscience are joining forces to provide insights into the day-to-day experiences of people living with psychiatric disorders, and …
Atsign and S-IMSY Partner to Deliver Cost-Effective IoT Solutions with Security Through Invisibility
GlobeNewswire
·
April 29, 2025
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Atsign, a pioneer in security through invisibility solutions, and S-IMSY, a leading provider of innovative SIM-based connectivity solutions, today announced a strategic partnership to deliver a …
As European carmakers navigate the autonomous car race, Lighty’s new AI edge software offers them a lifeline amid rising tariffs
GlobeNewswire
·
April 29, 2025
Zurich, April 29, 2025 (GLOBE NEWSWIRE) -- As European automakers face increasing tariffs and mounting pressure from American and Asian competitors in the autonomous driving race, leading Swiss AI startup Lightly today launches LightlyEdge – a …
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
GlobeNewswire
·
April 29, 2025
Two studies report favorable clinical outcomes and safety data for Renuvion® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin Rapid weight loss due to GLP-1 drugs expected to drive growth in patients …
Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025
GlobeNewswire
·
April 29, 2025
BRISBANE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its …
Annovis Bio Appoints Hui Liu as Director of Biostatistics
GlobeNewswire
·
April 29, 2025
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) …
Incyclix Bio Granted U.S. FDA Fast Track Designation for INX-315 to Treat CCNE1-Amplified Platinum-Resistant/Refractory Ovarian Cancer
GlobeNewswire
·
April 29, 2025
RESEARCH TRIANGLE PARK, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …
Employ’s Latest Report on Job Seeker Insights Helps Recruiters Fine-Tune Processes, Personalize Outreach and Stay Ahead of Hiring Trends
GlobeNewswire
·
April 29, 2025
DENVER, April 29, 2025 (GLOBE NEWSWIRE) -- Employ Inc., the market-leading intelligent hiring suite, announces today the release of the 2025 Job Seeker Nation report, providing a data-driven look into how job seekers perceive the market, candidates’ …
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
GlobeNewswire
·
April 29, 2025
WILMETTE, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that data on the long …
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF)
GlobeNewswire
·
April 29, 2025
WATERTOWN, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
APR Energy Delivers 150MW Fast Power to Support Mexico’s Grid
GlobeNewswire
·
April 29, 2025
JACKSONVILLE, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- New APR Energy LLC (“APR Energy”), a global leader in fast-track power generation, has secured a contract to deliver 150 megawatts (MW) of power generation to support Mexico’s national utility ahead of …
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors
GlobeNewswire
·
April 29, 2025
WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences
GlobeNewswire
·
April 29, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that it will present new clinical …
Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress
GlobeNewswire
·
April 29, 2025
CONSHOHOCKEN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six …
Immutep Quarterly Activities Report Q3 FY25
GlobeNewswire
·
April 29, 2025
Media Release First patient safely dosed in TACTI-004 Phase III lung cancer trial, marking a significant milestone Pivotal TACTI-004 trial design presented at the European Lung Cancer Congress (ELCC) 2025 Patient enrolment completed for the EFTISARC-NEO …
Reviva to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 29, 2025
CUPERTINO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of …
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical …